GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Other Current Liabilities

Y-Biologics (XKRX:338840) Other Current Liabilities : ₩2,296 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Other Current Liabilities?

Y-Biologics's other current liabilities for the quarter that ended in Mar. 2024 was ₩2,296 Mil.

Y-Biologics's quarterly other current liabilities declined from Sep. 2023 (₩8,083 Mil) to Dec. 2023 (₩3,052 Mil) and declined from Dec. 2023 (₩3,052 Mil) to Mar. 2024 (₩2,296 Mil).

Y-Biologics's annual other current liabilities declined from Dec. 2020 (₩13,129 Mil) to Dec. 2021 (₩2,804 Mil) but then increased from Dec. 2021 (₩2,804 Mil) to Dec. 2022 (₩10,791 Mil).

Y-Biologics Other Current Liabilities Historical Data

The historical data trend for Y-Biologics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Other Current Liabilities Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Liabilities
Get a 7-Day Free Trial - - - - -

Y-Biologics Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only - - - - -

Y-Biologics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Y-Biologics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics (XKRX:338840) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Other Current Liabilities
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR
Website
https://www.ybiologics.com
Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines